株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

NGSベースRNAシーケンシングの世界市場:SBS、SMRT、ナノポア - 2024年までの予測

NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024

発行 MarketsandMarkets 商品コード 509324
出版日 ページ情報 英文 157 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.69円で換算しております。
Back to Top
NGSベースRNAシーケンシングの世界市場:SBS、SMRT、ナノポア - 2024年までの予測 NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024
出版日: 2019年09月27日 ページ情報: 英文 157 Pages
概要

世界のNGSベースRNAシーケンシングの市場規模は、2019年には17億米ドル、2024年には42億米ドルと、20.0%のCAGR (複合年間成長率) で成長する見通しです。市場成長の主な要因として、RNAシーケンシング向けの政府補助金の増額や、研究開発 (R&D) 活動の活発化、精密医療の急成長などが挙げられます。用途別では発現プロファイリング分析が最大のシェアを占め、また地域別ではアジア太平洋地域が今後急速に成長する見込みです。

当レポートでは、世界におけるNGS (次世代シーケンシング) ベースのRNA-Seq (RNAシーケンス) 市場について分析し、市場の基本構造や最新情勢、主な市場促進・阻害要因、市場動向の見通し (過去2年間・今後6年間分)、製品/サービス別・技術別・用途別・地域別の詳細動向、市場競争の状態、主要企業のプロファイルなどを調査しております。

509324_4.1 NGS-BASED RNA-SEQUENCING MARKET OVERVIEW_FIGURE 13

第1章 イントロダクション

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場のダイナミクス
    • 促進要因
      • 従来型手法に対するRNAシーケンシングの利点
      • RNAシーケンシング向け助成金の増大
      • RNAシーケンシング関連の研究活動の増加
      • 精密医療の急成長
    • 抑制要因
      • 研究分野でのRNAシーケンシングの利用増加
      • 診察検査におけるRNAシーケンシングの標準化の問題
    • 市場機会
      • 研究分野でのRNAシーケンシングの利用拡大
        • がん研究
        • 農業研究
    • 課題
      • シーケンシングデータの保管 (ストレージ) と解釈
      • 新規転写の検出向けのRNAシーケンシング・データの分析

第6章 NGSベースRNAシーケンシング市場:製品・サービス別

  • イントロダクション
  • RNAシーケンシング用プラットフォーム/消耗品
  • 試料調整
    • ワークフロー別
      • ライブラリ調整・ターゲット濃縮
      • 品質管理
    • 手法別
      • 手動式試料調整
      • マイクロ流体式試料調整
      • ロボット式リキッドハンドリング/試料調整
  • RNAシーケンシング・サービス
  • データ解析・記憶・管理

第7章 NGSベースRNAシーケンシング市場:技術別

  • イントロダクション
  • SBS (Sequencing by Synthesis)
  • イオン半導体シーケンシング
  • SMRS (単一分子リアルタイムシーケンシング)
  • ナノポアシーケンシング

第8章 NGSベースRNAシーケンシング市場:用途別

  • イントロダクション
  • 発現プロファイリング分析
  • Small RNAシーケンシング
  • de novo トランスクリプトーム用アセンブリ
  • バリアント・コーリングとトランスクリプトーム・エピジェネティクス

第9章 NGSベースRNAシーケンシング市場:エンドユーザー別

  • イントロダクション
  • 教育・研究機関
  • 病院・診療所
  • 製薬・バイオテクノロジー企業
  • その他

第10章 NGSベースRNAシーケンシング市場:地域別

  • イントロダクション
  • 北米 (米国、カナダ)
  • 欧州 (ドイツ、英国、フランスなど)
  • アジア太平洋地域 (中国、日本、インドなど)
  • ラテンアメリカ (ブラジル、メキシコなど)
  • 中東・アフリカ

第11章 競争環境

  • イントロダクション
  • 企業戦略の方向性:マッピング
    • 先駆的企業
    • 革新的企業
    • 活動的企業
    • 新規企業
  • 競争シナリオ
  • 市場ランキング:大手3社の場合

第12章 企業プロファイル

  • AGILENT TECHNOLOGIES
  • BGI GROUP
  • EUROFINS SCIENTIFIC
  • GENEWIZ (BROOKS AUTOMATIONの一部門)
  • HAMILTON COMPANY
  • ILLUMINA
  • NUGEN TECHNOLOGIES (TECAN TRADING AGの一部門)
  • OXFORD NANOPORE TECHNOLOGIES
  • PERKINELMER
  • PSOMAGEN
  • QIAGEN
  • F. HOFFMANN-LA ROCHE AG
  • タカラバイオ
  • THERMO FISHER SCIENTIFIC
  • ZYMO RESEARCH

第13章 付録

図表

LIST OF TABLES

  • TABLE 1: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 2: RNA SEQUENCING PLATFORMS & CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 3: SAMPLE PREPARATION PRODUCTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4: RNA SEQUENCING SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: DATA ANALYSIS, STORAGE & MANAGEMENT MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 7: SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10: NANOPORE SEQUENCING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 12: EXPRESSION PROFILING ANALYSIS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: SMALL RNA SEQUENCING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: DE NOVO TRANSCRIPTOME ASSEMBLY MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: VARIANT CALLING & TRANSCRIPTOME EPIGENETICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 17: NGS-BASED RNA-SEQUENCING MARKET FOR RESEARCH & ACADEMIA, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: NGS-BASED RNA-SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: NGS-BASED RNA-SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: NGS-BASED RNA-SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: NGS-BASED RNA-SEQ MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 23: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 24: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 25: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 26: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 27: US: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 28: US: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 29: US: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 30: CANADA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 31: CANADA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 32: CANADA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 33: EUROPE: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34: EUROPE: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 35: EUROPE: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 36: EUROPE: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 37: EUROPE: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 38: GERMANY: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 39: GERMANY: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 40: GERMANY: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 41: UK: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 42: UK: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 43: UK: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 44: FRANCE: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 45: FRANCE: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 46: FRANCE: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 47: ROE: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 48: ROE: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 49: ROE: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 50: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 51: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 52: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 53: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 54: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 55: CHINA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 56: CHINA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 57: CHINA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 58: JAPAN: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 59: JAPAN: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 60: JAPAN: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 61: INDIA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 62: INDIA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 63: INDIA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 64: ROAPAC: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 65: ROAPAC: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 66: ROAPAC: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 67: LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 68: LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 69: LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 70: LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 71: LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 72: BRAZIL: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 73: BRAZIL: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 74: BRAZIL: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 75: MEXICO: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 76: MEXICO: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 77: MEXICO: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 78: ROLA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 79: ROLA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 80: ROLA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 81: MEA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 82: MEA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 83: MEA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 84: MEA: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 85: NEW PRODUCT LAUNCHES
  • TABLE 86: ACQUISITIONS
  • TABLE 87: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARIES
  • FIGURE 3: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4: PRODUCT-BASED MARKET ESTIMATION: NGS-BASED RNA-SEQUENCING MARKET
  • FIGURE 5: APPLICATION-BASED MARKET ESTIMATION: NGS-BASED RNA-SEQUENCING MARKET
  • FIGURE 6: DATA TRIANGULATION
  • FIGURE 7: ASSUMPTIONS OF THE RESEARCH STUDY
  • FIGURE 8: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: NGS-BASED RNA-SEQUENCING MARKET SHARE, BY APPLICATION, 2019 VS. 2024
  • FIGURE 11: NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 12: NGS-BASED RNA-SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 13: INCREASING NUMBER OF RESEARCH ACTIVITIES INVOLVING RNA-SEQ & RAPID GROWTH IN PRECISION MEDICINE TO DRIVE MARKET GROWTH
  • FIGURE 14: RNA SEQUENCING PLATFORMS & CONSUMABLES TO DOMINATE THE NGS-BASED RNA-SEQUENCING MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: SEQUENCING BY SYNTHESIS SEGMENT WILL CONTINUE TO DOMINATE THE NGS-BASED RNA-SEQUENCING MARKET IN 2024
  • FIGURE 16: EXPRESSION PROFILING ANALYSIS SEGMENT DOMINATES THE NGS-BASED RNA-SEQUENCING APPLICATIONS MARKET
  • FIGURE 17: RESEARCH & ACADEMIA ARE THE LARGEST END USERS OF NGS-BASED RNA-SEQUENCING
  • FIGURE 18: CHINA IS THE FASTEST-GROWING COUNTRY IN THE NGS-BASED RNA-SEQUENCING MARKET
  • FIGURE 19: NGS-BASED RNA-SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: GLOBAL FUNDING ACTIVITIES FOR RNA-SEQ AND MICROARRAY PROJECTS, 2009-2016
  • FIGURE 21: NUMBER OF RNA-SEQ PUBLICATIONS GLOBALLY, 2008-2016
  • FIGURE 22: NORTH AMERICA: NGS-BASED RNA-SEQ MARKET SNAPSHOT
  • FIGURE 23: EUROPE: NGS-BASED RNA-SEQ MARKET SNAPSHOT
  • FIGURE 24: ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET SNAPSHOT
  • FIGURE 25: NGS-BASED RNA-SEQUENCING MARKET, COMPETITIVE LEADERSHIP MAPPING, 2018 (OVERALL MARKET)
  • FIGURE 26: NGS BASED RNA-SEQUENCING MARKET, COMPETITIVE LEADERSHIP MAPPING, 2018 (SME/START-UPS)
  • FIGURE 27: KEY DEVELOPMENTS IN THE NGS BASED RNA-SEQUENCING MARKET, 2016-2019
  • FIGURE 28: ILLUMINA HELD THE LEADING POSITION IN THE NGS BASED RNA-SEQUENCING MARKET AS OF 2018
  • FIGURE 29: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2018)
  • FIGURE 30: EUROFINS: COMPANY SNAPSHOT (2018)
  • FIGURE 31: BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 32: ILLUMINA: COMPANY SNAPSHOT (2018)
  • FIGURE 33: TECAN: COMPANY SNAPSHOT (2018)
  • FIGURE 34: PERKIN ELMER: COMPANY SNAPSHOT (2018)
  • FIGURE 35: QIAGEN: COMPANY SNAPSHOT (2018)
  • FIGURE 36: ROCHE: COMPANY SNAPSHOT (2018)
  • FIGURE 37: TAKARA BIO: COMPANY SNAPSHOT (2017)
  • FIGURE 38: THERMO FISCHER: COMPANY SNAPSHOT (2018)
目次
Product Code: BT 5297

"The NGS-based RNA-sequencing market is projected to grow at a CAGR of 20.0%."

The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0%. Advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; rapid growth in precision medicine are the key factors driving the growth of the NGS based RNA sequencing industry.

"Pharmaceutical & biotechnology companies segment to witness the highest growth in the NGS-based RNA-sequencing market during the forecast period."

Based on the end-user, the NGS-based RNA-sequencing industry is segmented into research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The pharmaceutical & biotechnology companies segment is expected to witness highest growth rate during the forecast period mainly due to growing number of agreements and collaborations between NGS market players and pharmaceutical & biotechnology companies for the development of advanced products.

"Expression profiling analysis application to hold the largest share in the NGS-based RNA-sequencing market."

Based on application, the NGS-based market is segmented into expression profiling analysis, small RNA-sequencing, de novo transcriptome assembly, and variant calling & transcriptome epigenetics. In 2018, the expression profiling analysis segment accounted for the largest share mainly due to the increasing prevalence of metabolic disorders, multiple sclerosis, and other diseases will propel the demand for expression profiling analysis to provide specific treatment options in the market during the forecast period.

"The Asia Pacific market is expected to witness the highest CAGR during the forecast period."

The market in Asia Pacific is projected to register the highest CAGR during the forecast period. Significant focus on R&D activities as a means of broadening the scope of RNA-Seq applications and decreasing the costs of NGS products and services are some of the key factors supporting the growth of the NGS-based RNA-sequencing market in the Asia Pacific.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1: 45%, Tier 2: 34%, and Tier 3: 21%
  • By Designation: C-level: 47%, D-level: 33%, and Others: 20%
  • By Region: North America: 35%, Europe: 32%, APAC: 25%, Latin America: 6% and Middle East & Africa: 2%

The major players operating in the NGS-based RNA-sequencing market are: Illumina (US), Thermo Fischer Scientific (US) and Oxford Nanopore (UK), Agilent Technologies, Inc. (US), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (US), Hamilton Company (US), Macrogen (South Korea), Zymo Research (US), and Tecan Genomics, Inc. (Switzerland) among others are the major players operating in the NGS-based RNA-sequencing market

Research Coverage:

This report studies the NGS-based RNA-sequencing market based on product & service, technology, application, end user, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their growth trends and forecasts the size of market segments with respect to key regions-North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa (and the respective countries in these regions).

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-market ranking analysis of the top players and their company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the NGS-based RNA-sequencing market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 APPLICATION-BASED MARKET ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 NGS-BASED RNA-SEQUENCING: MARKET OVERVIEW
  • 4.2 NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
  • 4.3 NGS-BASED RNA-SEQUENCING MARKET SHARE, BY TECHNOLOGY, 2019 VS. 2024
  • 4.4 NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • 4.5 NGS-BASED RNA-SEQUENCING MARKET SHARE, BY END USER, 2019 VS. 2024
  • 4.6 GEOGRAPHICAL SNAPSHOT OF THE NGS-BASED RNA-SEQUENCING MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Advantages of RNA-seq over conventional technologies
      • 5.2.1.2 Increasing number of RNA-seq grants
      • 5.2.1.3 Growing number of research activities involving RNA-seq
      • 5.2.1.4 Rapid growth in precision medicine
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lack of skilled professionals
      • 5.2.2.2 Standardization concerns of RNA-seq in diagnostic testing
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing applications of RNA-seq in research
        • 5.2.3.1.1 Cancer research
        • 5.2.3.1.2 Agricultural research
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Storage & interpretation of sequencing data
      • 5.2.4.2 Analysis of RNA-seq data for the detection of novel transcripts

6 NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 RNA SEQUENCING PLATFORMS & CONSUMABLES
    • 6.2.1 INCREASING AVAILABILITY OF PLATFORMS AND GROWING CONSUMABLE USAGE HAVE ENSURED THE HIGH SHARE OF THIS SEGMENT
  • 6.3 SAMPLE PREPARATION PRODUCTS
    • 6.3.1 SAMPLE PREPARATION IS THE FIRST STEP OF AN NGS WORKFLOW
    • 6.3.2 SAMPLE PREPARATION PRODUCTS, BY WORKFLOW
      • 6.3.2.1 Library preparation & target enrichment
      • 6.3.2.2 Quality control
    • 6.3.3 SAMPLE PREPARATION PRODUCTS, BY METHOD
      • 6.3.3.1 Manual sample preparation
      • 6.3.3.2 Microfluidic sample preparation
      • 6.3.3.3 Robotic liquid handling sample preparation
  • 6.4 RNA SEQUENCING SERVICES
    • 6.4.1 LACK OF INFRASTRUCTURE AND EXPERTISE AMONG END USERS HAS DRIVEN DEMAND FOR SERVICES
  • 6.5 DATA ANALYSIS, STORAGE & MANAGEMENT
    • 6.5.1 INTEGRATION OF CLOUD COMPUTING AND BIOINFORMATICS, AMONG OTHER ADVANCEMENTS, IS CONTRIBUTING TO MARKET GROWTH

7 NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 SEQUENCING BY SYNTHESIS
    • 7.2.1 SBS TECHNOLOGY ENABLES THE HIGHEST PRODUCTION OF BASE PAIRS IN A SHORT PERIOD OF TIME
  • 7.3 ION SEMICONDUCTOR SEQUENCING
    • 7.3.1 ION SEMICONDUCTOR SEQUENCING PLATFORMS POSSESS HIGH-THROUGHPUT CAPABILITIES
  • 7.4 SINGLE-MOLECULE REAL-TIME SEQUENCING
    • 7.4.1 SMRT SEQUENCING PRODUCES RESULTS IN A SHORT TIME AND AT LOWER COSTS
  • 7.5 NANOPORE SEQUENCING
    • 7.5.1 NANOPORE SEQUENCING IS THE ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA-SEQUENCING CAPABILITIES

8 NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 EXPRESSION PROFILING ANALYSIS
    • 8.2.1 INCREASING NEED FOR IMPROVED PROGNOSIS OF PATIENTS TO PROPEL MARKET GROWTH
  • 8.3 SMALL RNA SEQUENCING
    • 8.3.1 RISING NEED FOR ACCURATE DIAGNOSTIC ANALYSIS TO SUPPORT MARKET GROWTH
  • 8.4 DE NOVO TRANSCRIPTOME ASSEMBLY
    • 8.4.1 INCREASING CANCER CASES IS EXPECTED TO DRIVE THIS APPLICATION SEGMENT
  • 8.5 VARIANT CALLING & TRANSCRIPTOME EPIGENETICS
    • 8.5.1 COMPLICATED RNA-SEQ DATA ANALYSIS MAY HAMPER THE GROWTH OF THIS SEGMENT

9 NGS-BASED RNA-SEQUENCING MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 RESEARCH & ACADEMIA
    • 9.2.1 INCREASING NUMBER OF COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND ACADEMIC & RESEARCH INSTITUTES TO PROPEL MARKET GROWTH
  • 9.3 HOSPITALS & CLINICS
    • 9.3.1 INCREASING ADOPTION OF NGS SYSTEMS IN HOSPITALS & CLINICS TO DRIVE MARKET GROWTH
  • 9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.4.1 CONSOLIDATION BETWEEN BIOTECH & PHARMA COMPANIES AND NGS MARKET PLAYERS TO PROPEL MARKET GROWTH
  • 9.5 OTHER END USERS

10 NGS-BASED RNA-SEQUENCING MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 Favorable funding scenario and growing R&D activity in the US are driving market growth
    • 10.2.2 CANADA
      • 10.2.2.1 Government initiatives for genome research will boost the adoption of NGS sequencing technology
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany dominates the NGS-based RNA-sequencing market in Europe
    • 10.3.2 UK
      • 10.3.2.1 Strong presence of NGS organizations and supportive initiatives will drive market growth in the UK
    • 10.3.3 FRANCE
      • 10.3.3.1 Growing awareness on applications of high-throughput sequencing in genetic characterization will support market growth
    • 10.3.4 ROE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 Strong base of established players and favorable government initiatives account for China's large market share
    • 10.4.2 JAPAN
      • 10.4.2.1 Growing awareness and rising incidence of genetic disorders are driving demand for NGS-based RNA-Seq in Japan
    • 10.4.3 INDIA
      • 10.4.3.1 Rising awareness and player interest in India will drive market growth
    • 10.4.4 ROAPAC
  • 10.5 LATIN AMERICA
    • 10.5.1 BRAZIL
      • 10.5.1.1 High HIV prevalence in Brazil has driven demand for NGS in research
    • 10.5.2 MEXICO
      • 10.5.2.1 Economic growth and support for infrastructural development will drive market growth in Mexico
    • 10.5.3 ROLA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 LACK OF INFRASTRUCTURE HAS STIFLED MARKET GROWTH IN THE MEA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 COMPETITIVE LEADERSHIP MAPPING
    • 11.2.1 TERMINOLOGY/NOMENCLATURE
      • 11.2.1.1 Visionary leaders
      • 11.2.1.2 Innovators
      • 11.2.1.3 Dynamic differentiators
      • 11.2.1.4 Emerging companies
  • 11.3 COMPETITIVE SCENARIO (2015-2019)
  • 11.4 NGS-BASED RNA-SEQUENCING MARKET RANKING, BY TOP THREE MARKET PLAYERS (2018)

12 COMPANY PROFILES

(Business overview, Products offered, Recent developments, MNM view)*

  • 12.1 AGILENT TECHNOLOGIES
  • 12.2 BGI GROUP
  • 12.3 EUROFINS SCIENTIFIC
  • 12.4 GENEWIZ (PART OF BROOKS AUTOMATION)
  • 12.5 HAMILTON COMPANY
  • 12.6 ILLUMINA
  • 12.7 NUGEN TECHNOLOGIES (PART OF TECAN TRADING AG)
  • 12.8 OXFORD NANOPORE TECHNOLOGIES
  • 12.9 PERKINELMER
  • 12.10 PSOMAGEN
  • 12.11 QIAGEN
  • 12.12 F. HOFFMANN-LA ROCHE AG
  • 12.13 TAKARA BIO
  • 12.14 THERMO FISHER SCIENTIFIC
  • 12.15 ZYMO RESEARCH

Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Back to Top